Nasdaq Bumps DeCode from Global Market | GenomeWeb

NEW YORK (GenomeWeb News) — DeCode Genetics' stock has been moved from the Nasdaq Global Market to the Nasdaq Capital Market after failing to maintain a minimum market value for listed shares, the company said today.

Nasdaq decided to move DeCode to the Capital Market, which is one of three Nasdaq tiers, after a review hearing on Dec. 18, 2008, regarding its non-compliance with the market's rules.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: weighting scheme increases GWAS power, and more.

Marc Tessier-Lavigne is to be the next president of Stanford University.

Walgreens has given Theranos 30 days to fix its lab issues, the Wall Street Journal reports.

Journals and research funding agencies pledge to enable the sharing of Zika virus research.